TMO Stock Analysis: Buy, Sell, or Hold?
TMO - Thermo Fisher Scientific, Inc.
$488.77
19.42 (4.14%)
▲
5d:
+3.41%
30d:
+9.03%
90d:
-0.31%
SELL
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 22, 2026
27d
Smart Money Accumulation
None View Scanner →
Strength: 6.8/10
Get Alerted When TMO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⚠️ CAUTION: TMO is extended with warning signals. Consider taking profits or waiting for better entry.
⚠️ CAUTION: TMO is extended with warning signals. Consider taking profits or waiting for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$749.03
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$465.09
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TMO is currently trading at $488.77, which is considered extended relative to its 30-day fair value range of $454.40 to $485.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.2) compared to its historical average (19.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.6% over the next few years. This pessimistic expectation contrasts with the company's recent 11.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is approaching resistance at $499.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: TMO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $599.19 (+27.7%). Given the valuation headwinds and technical position, caution is warranted at these levels.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is approaching resistance at $499.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: TMO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $599.19 (+27.7%). Given the valuation headwinds and technical position, caution is warranted at these levels.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$454.40 -
$485.15
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
33.3%
Protect Your Profits
Before you sell your TMO shares, consider hedging with options to lock in your gains without triggering a tax event.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 27.7% below Wall St target ($599.19)
Trading Range Analysis
30-Day Trading Range
$454.40 -
$485.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$447.44
Resistance Level
$499.00
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.22
Wall Street Target
$599.19
(+27.7%)
Revenue Growth (YoY)
6.2%
Earnings Growth (YoY)
11.3%
Profit Margin
15.2%
Valuation Discount vs History
-4.6% cheaper
PE vs Historical
17.2 vs 19.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.6%
(market-implied from PE analysis)
1-Year Target
$447.76
(-5%)
2-Year Target
$427.16
(-9%)
3-Year Target
$407.51
(-13%)
3-Yr Target (if PE normalizes)
(PE: 17→20)
$468.45
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.6%)
$782.03
(+67%)
Base:
(SPY PE: 17.2, Growth: 9.6%)
$618.46
(+32%)
Bear:
(PE: 14.6, Growth: 9.6%)
$525.69
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 25.51 | Current EPS (TTM): $18.19
Bull Case
$764.61
(+63%)
Analyst growth 49.8%, PE expands to 28.1
Base Case
$695.10
(+48%)
Market implied 49.8%, PE stable at 25.5
Bear Case
$315.53
(-33%)
Severe decline -20.0%, PE contracts to 21.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.2 to 19.8
Stabilization Target:
$539.53
(+15.0%)
PE Expansion Potential:
+15.0%
Share & Embed Analysis
Last updated: June 24, 2026 12:21 PM ET
Data refreshes hourly during market hours. Next update: 1:21 PM
Data refreshes hourly during market hours. Next update: 1:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-10
Ro Khanna
BUY
2026-03-06
Marc N Casper
SELL
5000 shares
2026-03-04
Featured in Portfolios
TMO is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 59 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 63 BUY |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$310 | 60 HOLD |
Advanced TMO Option Strategies
Professional options setups generated by AI based on today's TMO price and gamma walls.
